{"SLR NAME":"The novel 2019 coronavirus (nCoV) infection in humans: a systematic review protocol","References":[{"title1":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title2":"China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Published January 28, 2020. Accessed January 31, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected","References":[]},{"title2":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","References":[]},{"title2":"Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score","References":[]},{"title2":"Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)","References":[]},{"title2":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors"},{"title3":"Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome"},{"title3":"Autopsy findings in eight patients with fatal H1N1 influenza"},{"title3":"H5N1-infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in Vietnam"},{"title3":"Clinical aspects of pandemic 200 influenza A (H1N1) virus infection"},{"title3":"Acute effects of upright position on gas exchange in patients with acute respiratory distress syndrome"},{"title3":"Advantages and limitations of current network inference methods"},{"title3":"Eigengene networks for studying the relationships between co-expression modules"},{"title3":"Defining clusters from a hierarchical cluster tree: the Dynamic tree cut package for R"},{"title3":"Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target"},{"title3":"Identification of cis-regulatory elements in gene co-expression networks using A-GLAM"},{"title3":"Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells"},{"title3":"A general framework for weighted gene co-expression network analysis"},{"title3":"A mouse adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung"},{"title3":"Matrix metalloproteases in aberrant fibrotic tissue remodeling"},{"title3":"Role of tissue plasminogen activator in acute ischemic stroke"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Synthetic reconstruction of zoonotic and early human SARS-CoV isolates that produce fatal disease in aged mice"},{"title3":"WGCNA: an R package for weighted correlation network analysis"},{"title3":"The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo"},{"title3":"Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice"},{"title3":"Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome"},{"title3":"Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases"},{"title3":"Molecular mechanisms of fibrinolysis"},{"title3":"Plasma protein composition of hyaline membrane in the newborn as studies by immunofluorescence"},{"title3":"Nonhomogeneous immunostaining of hyaline membranes in different manifestations of diffuse alveolar damage"},{"title3":"Surfactant proteins: role in lung physiology and disease in early life"},{"title3":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles"},{"title3":"GOstat: find statistically overrepresented gene ontologies within a group of genes"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis"},{"title3":"Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome"},{"title3":"Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China"},{"title3":"Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million-person population base"},{"title3":"Response network analysis of differential gene expression in human epithelial lung cells during avian influenza infections"},{"title3":"Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction"},{"title3":"Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency"},{"title3":"Epithelial and surfactant changes in influenzal pulmonary lesions"},{"title3":"Alveolitis and collapse in the pathogenesis of pulmonary fibrosis"},{"title3":"Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D"},{"title3":"The role of fibrin degradation products in neutrophil recruitment to the lung"},{"title3":"Inhibition of neutrophil apoptosis by PAI-1"},{"title3":"H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients"},{"title3":"Retrospective analysis of necropsy findings in patients of H1N1 and their correlation to clinical features"},{"title3":"CYLD negatively regulates transforming growth factor-beta-signalling via deubiquitinating Akt"},{"title3":"A plasminogen-activating protease specifically controls the development of primary pneumonic plague"},{"title3":"Systems biology of vaccination for seasonal influenza in humans"},{"title3":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"The control of the false discovery rate in multiple testing under dependency"}]},{"title2":"Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis","References":[{"title3":"Knipe DM, Howley PM, editors (2006) Fields Virology. 5th edition. Philadelphia (Pennsylvania): Lippincott, Williams, &amp; Wilkins."},{"title3":"Pathogenesis of influenza virus infections: the good, the bad and the ugly"},{"title3":"A question of self-preservation: immunopathology in influenza virus infection"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The role of protease activation of inflammation in allergic respiratory diseases"},{"title3":"A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors"},{"title3":"Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response"},{"title3":"Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling"},{"title3":"PAR1 contributes to influenza A virus pathogenicity in mice"},{"title3":"Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin"},{"title3":"Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase"},{"title3":"A novel mechanism for the acquisition of virulence by a human influenza A virus"},{"title3":"Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus"},{"title3":"Endothelium-role in regulation of coagulation and inflammation"},{"title3":"Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1"},{"title3":"Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells"},{"title3":"Basis of antifibrinolytic therapy"},{"title3":"Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice"},{"title3":"Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung"},{"title3":"Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway"},{"title3":"S100A10 regulates plasminogen-dependent macrophage invasion"},{"title3":"Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice"},{"title3":"Reduced transplant arteriosclerosis in plasminogen-deficient mice"},{"title3":"Clinical course of avian influenza A(H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008"},{"title3":"Serum D-dimer changes and prognostic implication in 2009 novel influenza A(H1N1)"},{"title3":"Pandemic 2009 H1N1 virus infection associated with purpuric skin lesions: a case report"},{"title3":"A case of hemorrhagic colitis after influenza A infection"},{"title3":"Fibrin and fibrinolysis in infection and host defense"},{"title3":"Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection"},{"title3":"Multiorgan distribution of human influenza A virus strains observed in a mouse model"},{"title3":"Influenza A virus in the mouse: hepatic and cerebral lesions in a Reye's syndrome-like illness"},{"title3":"Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus"},{"title3":"Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases"},{"title3":"TMPRSS2 and TMPRSS4 facilitate trypsin-independent influenza virus spread in Caco-2 cells"},{"title3":"Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium"},{"title3":"Proteolytic activation of the 1918 influenza virus hemagglutinin"},{"title3":"Aprotinin and similar protease inhibitors as drugs against influenza"},{"title3":"Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors"},{"title3":"Protective effect of protease inhibitors in influenza virus infected animals"},{"title3":"Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets"},{"title3":"The first specific detection of a highly pathogenic avian influenza virus (H5N1) in Ivory Coast"},{"title3":"Two novel fibrinogen variants found in patients with pulmonary embolism and their families"},{"title3":"Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice"},{"title3":"Costimulatory receptors in a teleost fish: typical CD28, elusive CTLA4"},{"title3":"Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice"},{"title3":"Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line"},{"title3":"Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway"},{"title3":"Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection"},{"title3":"Exosomes bearing HLA-G are released by melanoma cells"}]}]},{"title1":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China","References":[{"title2":"Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet. S0140-6736(20)30185-30189","References":[]},{"title2":"Emerging coronaviruses: Genome structure, replication, and pathogenesis","References":[{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"}]},{"title2":"Chan JF, Yuan S, Kok KH et al (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet S0140-6736(20)30154-30159","References":[]},{"title2":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet S0140-6736(20)30183-30185","References":[]},{"title2":"Tan W, Zhao X, Ma X et al (2020) A novel coronavirus genome identified in a cluster of pneumonia cases- Wuhan, China 2019-2020. China CDC Weekly 2:61-62. Available via http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c","References":[]}]},{"title1":"Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study","References":[{"title2":"Using &quot;outbreak science&quot; to strengthen the use of models during epidemics","References":[]},{"title2":"Severe respiratory disease concurrent with the circulation of H1N1 influenza","References":[]},{"title2":"Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico","References":[{"title3":"Severe respiratory disease concurrent with the circulation of H1N1 influenza."},{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico."},{"title3":"Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosi, Mexico."},{"title3":"Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009."},{"title3":"Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009."},{"title3":"The influenza A(H1N1) epidemic in Mexico. Lessons learned."},{"title3":"The effect of public health measures on the 1918 influenza pandemic in U.S. cities."},{"title3":"Absolute humidity modulates influenza survival, transmission, and seasonality."},{"title3":"Absolute humidity and the seasonal onset of influenza in the continental United States."},{"title3":"H1N1 Flu."},{"title3":"Pandemic potential of a strain of influenza A (H1N1): early findings."},{"title3":"The early transmission dynamics of H1N1pdm influenza in the United Kingdom."},{"title3":"The transmissibility and control of pandemic influenza A (H1N1) virus."},{"title3":"Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan."},{"title3":"Changes in the viral distribution pattern after the appearance of the novel influenza A H1N1 (pH1N1) virus in influenza-like illness patients in Peru."},{"title3":"Monitoring influenza activity in Europe with Google Flu Trends: comparison with the findings of sentinel physician networks - results for 2009-10."},{"title3":"Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis."},{"title3":"Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine."},{"title3":"The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact."},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers."},{"title3":"Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations."},{"title3":"Comparative estimation of the reproduction number for pandemic influenza from daily case notification data."},{"title3":"Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States."},{"title3":"Comparative epidemiology of pandemic and seasonal influenza A in households."},{"title3":"Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981."},{"title3":"Closure of schools during an influenza pandemic."},{"title3":"School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States."},{"title3":"Estimating the impact of school closure on influenza transmission from Sentinel data."},{"title3":"Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009."},{"title3":"Case fatality ratio of pandemic influenza."},{"title3":"Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009."},{"title3":"School closure and mitigation of pandemic (H1N1) 2009, Hong Kong."},{"title3":"Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries."},{"title3":"[Asian influenza surveillance.]."},{"title3":"Epidemiologic studies of Asian influenza in a Louisiana parish."},{"title3":"Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America."},{"title3":"A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009."},{"title3":"Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1) 2009."},{"title3":"Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations."},{"title3":"Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May - 3 June 2009."},{"title3":"Epidemiological and transmissibility analysis of influenza A(H1N1)v in a southern hemisphere setting: Peru."},{"title3":"Outbreak of 2009 pandemic influenza A(H1N1), Los Lagos, Chile, April-June 2009."},{"title3":"Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza."},{"title3":"Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA."},{"title3":"Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school."},{"title3":"Current situation of the 2009 H1N1pdm influenza pandemic in Mexico [in Spanish]."},{"title3":"Situacion de influenza A(H1N1) - reporte 01/26/2010."},{"title3":"Situacion de influenza A(H1N1) - parte 87."},{"title3":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand."},{"title3":"Australia's winter with the 2009 pandemic influenza A (H1N1) virus."},{"title3":"The signature features of influenza pandemics--implications for policy."},{"title3":"Estimation of the reproductive number of the Spanish flu epidemic in Geneva, Switzerland."},{"title3":"Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies."},{"title3":"Detection of human influenza virus in Yucatan, Mexico."},{"title3":"Absolute humidity and pandemic versus epidemic influenza."},{"title3":"Influenza seasonality: lifting the fog."},{"title3":"Synchrony, waves, and spatial hierarchies in the spread of influenza."},{"title3":"Eggo RM, Cauchemez S, Ferguson NM Spatial dynamics of the 1918 influenza pandemic in England, Wales and the United States."},{"title3":"Rurality and pandemic influenza: geographic heterogeneity in the risks of infection and death in Kanagawa, Japan (1918-1919)."},{"title3":"Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009."},{"title3":"The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis."},{"title3":"Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina."},{"title3":"The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong."},{"title3":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California."},{"title3":"Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza AH1N1 2009."},{"title3":"Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City."},{"title3":"Transmissibility and geographic spread of the 1889 influenza pandemic."},{"title3":"H1N1 in post-pandemic period."}]},{"title2":"Pandemic potential of a strain of influenza A (H1N1): early findings","References":[]},{"title2":"Transmission dynamics and control of severe acute respiratory syndrome","References":[]},{"title2":"Characterizing Ebola transmission patterns based on internet news reports","References":[]},{"title2":"Pneumonia","References":[]},{"title2":"Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic","References":[{"title3":"World Health Organisation"},{"title3":"Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico"},{"title3":"Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza"},{"title3":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans"},{"title3":"Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine"},{"title3":"Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus"},{"title3":"Mortality and morbidity burden associated with A/H1N1pdm influenza virus"},{"title3":"Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989"},{"title3":"1918 Influenza: the mother of all pandemics"},{"title3":"Influenza--United States, 1989-90 and 1990-91 seasons"},{"title3":"Centers for Disease Control and Prevention"},{"title3":"Reseau Sentinelles"},{"title3":"Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity"},{"title3":"Centers for Disease Control and Prevention"},{"title3":"National Bureau of Economic research"},{"title3":"Centre d'Epidemiologie sur les causes medicales de deces"},{"title3":"Centers for Disease Control and Prevention"},{"title3":"Institut de Veille Sanitaire"},{"title3":"Surveillance Epidemiology and End Results du National Cancer Institute"},{"title3":"Institut National de la Statistique et des Etudes Economiques"},{"title3":"World Health Organisation"},{"title3":"The global impact of influenza on morbidity and mortality"},{"title3":"Mortality associated with influenza and respiratory syncytial virus in the United States"},{"title3":"Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness"},{"title3":"Comparison of infection rats and severity of illness for influenza A subtypes H1N1 and H3N2"},{"title3":"Differences in patient age distribution between influenza A subtypes"},{"title3":"Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981"},{"title3":"Emerging infections: pandemic influenza"},{"title3":"The pathology of influenza virus infections"},{"title3":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study"},{"title3":"Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment"},{"title3":"Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-react against 2009 Pandemic H1N1 Influenza Virus"},{"title3":"Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain"},{"title3":"Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis"},{"title3":"Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina"},{"title3":"On the doctrine of original antigenic sin"}]},{"title2":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020","References":[{"title3":"World Health Organization (WHO). WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China. Beijing: WHO; 9 Jan 2020. [Accessed 26 Jan 2020]. https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china "},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Imai N, Dorigatti I, Cori A, Donnelly C, Riley S, Ferguson NM. Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. London; 2020. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/2019-nCoV-outbreak-report-22-01-2020.pdf "},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study."},{"title3":"The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020."},{"title3":"Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly CA, Riley S, et al. Report 3: Transmissibility of 2019-nCoV. London; 2020. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-2019-nCoV-transmissibility.pdf "},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak."},{"title3":"Online repository. Boston: Laboratory for the Modeling of Biological and Socio-technical Systems (MOBS). [Accessed 29 Jan 2020]. Available from: https://docs.google.com/spreadsheets/d/1jS24DjSPVWa4iuxuD4OAXrE3QeI8c9BC1hSlqr-NMiU/edit#gid=1449891965 "},{"title3":"Stan Development Team. RStan: the R interface to Stan. R package version 2.18.2. 2018. Available from: https://cran.r-project.org/web/packages/rstan/vignettes/rstan.html "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"European Centre for Disease Prevention and Control (ECDC). Q &amp; A on novel coronavirus. Stockholm: ECDC; 2020. [Accessed 4 Feb 2020]. Available from: https://www.ecdc.europa.eu/en/novel-coronavirus-china/questions-answers "},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia."},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)."},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong."},{"title3":"Erratum to Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong."},{"title3":"Alternative methods of estimating an incubation distribution: examples from severe acute respiratory syndrome."},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan."},{"title3":"Incubation periods of acute respiratory viral infections: a systematic review."},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus."},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility."},{"title3":"Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia."}]},{"title2":"The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application","References":[]},{"title2":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak","References":[{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future"},{"title3":"A preliminary analysis of the epidemiology of influenza A (H1N1) v virus infection in Thailand from early outbreak data, June-July 2009"},{"title3":"Comments on &quot;Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak&quot;"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Modeling the spread of Middle East respiratory syndrome coronavirus in Saudi Arabia"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Simple framework for real-time forecast in a data-limited situation: the Zika virus (ZIKV) outbreaks in Brazil from 2015 to 2016 as an example"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Hospitalizations for severe lower respiratory tract infections","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients","References":[]},{"title2":"Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study","References":[{"title3":"World Health Organization (2010) Pandemic (H1N1) 2009:update 112. Available: http://www.who.int/csr/don/2010_08_06/en/index.html. Accessed 12 October 2012."},{"title3":"Virus of the year. The novel H1N1 influenza"},{"title3":"The handling of the H1N1 pandemic: more transparency needed"},{"title3":"Pandemic versus epidemic influenza mortality: a pattern of changing age distribution"},{"title3":"Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic"},{"title3":"The signature features of influenza pandemics:implications for policy"},{"title3":"Prioritization of influenza pandemic vaccination to minimize years of life lost"},{"title3":"Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons"},{"title3":"Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza"},{"title3":"Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic"},{"title3":"All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009"},{"title3":"Were equatorial regions less affected by the 2009 influenza pandemic? The Brazilian experience"},{"title3":"Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children"},{"title3":"Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China"},{"title3":"Response to the first wave of pandemic (H1N1) 2009: experiences and lessons learnt from China"},{"title3":"Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis"},{"title3":"Epidemiological characteristics of the influenza A(H1N1) 2009 pandemic in the Western Pacific Region"},{"title3":"Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis"},{"title3":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study"},{"title3":"World Health Organization (2013) FluNet [database]. Available: http://www.who.int/influenza/gisrs_laboratory/flunet/en/. Accessed 22 October 2013."},{"title3":"World Health Organization (2011) Summary of WHO technical consultation: H1N1pdm mortality estimates. Available: http://www.who.int/influenza/surveillance_monitoring/updates/MortalityEstimates/en/. Accessed 26 October 2013."},{"title3":"Assessing the burden of influenza and other respiratory infections in England and Wales"},{"title3":"Mortality associated with influenza and respiratory syncytial virus in the United States"},{"title3":"Estimates of US influenza-associated deaths made using four different methods"},{"title3":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008"},{"title3":"Buuren S (2012) Flexible imputation of missing data. Boca Raton (Florida): CRC Press."},{"title3":"World Health Organization (2013) Global health observatory data repository [database]. Available: http://apps.who.int/gho/data/view.main. Accessed 11 November 2011."},{"title3":"World Bank (2013) Data: indicators [database]. Available: http://data.worldbank.org/indicator/. Accessed 1 November 2011."},{"title3":"United Nations Statistics Division (2013) UNdata: explorer [database]. Available: http://data.un.org/Explorer.aspx?d=POP. Accessed 1 November 2011."},{"title3":"Thematic Mapping (2013) World borders database [database]. Available: http://thematicmapping.org/downloads/world_borders.php. Accessed 1 November 2011."},{"title3":"Raudenbush SW, Bryk AS (2002) Hierarchical linear models, applications and data analysis methods. Thousand Oaks (California): Sage Publications."},{"title3":"League tables and their limitations: statistical issues in comparisons of institutional performance"},{"title3":"Statistical methods for profiling providers of medical care: issues and applications"},{"title3":"Amelia II: a program for missing data"},{"title3":"Hasbash J, Charlton C, Browne WJ, Healy M, Cameron B (2009) MLwiN, version 2.1. Bristol: Centre for Multilevel Modelling, University of Bristol."},{"title3":"Current concepts in validity and reliability for psychometric instruments: theory and application"},{"title3":"World Health Organization (2005) WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics. WHO/CDS/CSR/GIP/20055. Geneva: World Health Organization."},{"title3":"Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies"},{"title3":"Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City"},{"title3":"Severe respiratory disease concurrent with the circulation of H1N1 influenza"},{"title3":"Pandemic potential of a strain of influenza A (H1N1): early findings"},{"title3":"Pandemic H1N1 influenza lessons from the southern hemisphere"},{"title3":"Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010"},{"title3":"Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus"},{"title3":"Influenza-associated mortality in 2009 in four sentinel sites in Bangladesh"},{"title3":"Epidemiology, seasonality, and burden of influenza and influenza-like illness in urban and rural Kenya, 2007-2010"},{"title3":"Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom"},{"title3":"Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity"},{"title3":"Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity"},{"title3":"Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong"},{"title3":"EuroMOMO (2013) European mortality bulletin, week 23, 2013. Copenhagen: EuroMOMO."},{"title3":"The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong"},{"title3":"Impact of seasonal and pandemic influenza on emergency department visits, 2003-2010, Ontario, Canada"},{"title3":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010)"},{"title3":"Association between the 2008?09 seasonal influenza vaccine and pandemic H1N1 illness during spring?summer 2009: four observational studies from Canada"}]},{"title2":"Risk of 2019 novel coronavirus importations throughout China prior to the Wuhan quarantine","References":[]},{"title2":"Exposure patterns driving ebola transmission in west Africa: A retrospective observational study","References":[{"title3":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak"},{"title3":"Emergence of Zaire Ebola virus disease in Guinea"},{"title3":"Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned"},{"title3":"Ebola haemorrhagic fever in Zaire, 1976"},{"title3":"Report of a WHO/International Study Team"},{"title3":"What factors might have led to the emergence of Ebola in West Africa"},{"title3":"Ebola virus disease in West Africa:no early end to the outbreak"},{"title3":"Ebola virus disease in West Africa:the first 9 months of the epidemic and forward projections"},{"title3":"West African Ebola epidemic after one year:slowing but not yet under control"},{"title3":"Ebola virus disease among children in West Africa"},{"title3":"Ebola virus disease among male and female persons in West Africa"},{"title3":"National Institute of Standards and Technology. Secure Hash Standard (SHS). FIPS 180-4. Gaithersburg (Maryland): National Institute of Standards and Technology; 2015 Aug [cited 2016 Oct 20]. Available from: http://csrc.nist.gov/publications/fips/fips180-4/fips-180-4.pdf."},{"title3":"Estimating individual and household reproduction numbers in an emerging epidemic"},{"title3":"A new framework and software to estimate time-varying reproduction numbers during epidemics"},{"title3":"Regression techniques for the detection of analytical bias"},{"title3":"Therneau T. deming: Deming, Thiel-Sen and Passing-Bablock Regression. Version 1.0-1. R Project for Statistical Computing; 2014 Sep 24 [cited 2016 Oct 12]. Available from: http://CRAN.R-project.org/package=deming."},{"title3":"R Foundation. The R Project for Statistical Computing. Vienna: R Foundation; 2014 [cited 2016 Oct 20]. Available from: https://www.r-project.org/."},{"title3":"Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit"},{"title3":"Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008"},{"title3":"Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Rapid assessment of Ebola infection prevention and control needs:six districts, Sierra Leone, October 2014"},{"title3":"Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study"},{"title3":"Cluster of Ebola virus disease, Bong and Montserrado Counties, Liberia"},{"title3":"Controlling the last known cluster of Ebola virus disease:Liberia, January-February 2015"},{"title3":"Epidemiology and risk factors for Ebola virus infection in Sierra Leone:May 23, 2014-January 31, 2015"},{"title3":"Decreased Ebola transmission after rapid response to outbreaks in remote areas, Liberia, 2014"},{"title3":"Lamunu M, Lutwama JJ, Kamugisha J, Opio A, Nambooze J, Ndayimirije N, et al. Containing hemorrhagic fever epidemic, the ebola experience in Uganda (October 2000-January 2001). 10th International Congress on Infectious Diseases; 2002 Mar 11-14; Singapore."},{"title3":"Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure"},{"title3":"The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Medecins Sans Frontieres (MSF) Ebola Case Management Centre (CMC), Kailahun, Sierra Leone, June-October, 2014"},{"title3":"Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014"},{"title3":"The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995"},{"title3":"Temporal variability and social heterogeneity in disease transmission: the case of SARS in Hong Kong"},{"title3":"Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore"},{"title3":"Super-spreaders in infectious diseases"},{"title3":"Middle East respiratory syndrome: a global health challenge"},{"title3":"Multiscale, resurgent epidemics in a hierarchical metapopulation model"},{"title3":"Dynamics and control of diseases in networks with community structure"},{"title3":"The ring vaccination trial: a novel cluster randomized controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola"},{"title3":"Ebola transmission linked to a single traditional funeral ceremony:Kissidougou, Guinea, December, 2014-January 2015"},{"title3":"Liberia confirms Ebola case two months after being declared free of the disease"}]}]},{"title1":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","References":[{"title2":"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","References":[]},{"title2":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","References":[]},{"title2":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","References":[]},{"title2":"Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease","References":[]},{"title2":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients","References":[{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Avian influenza virus (H5N1): a threat to human health"},{"title3":"Pandemic threat posed by avian influenza A viruses"},{"title3":"Preventing pandemics: the fight over flu"},{"title3":"Human infection with a novel avian-origin influenza A (H7N9) virus"},{"title3":"Why we should be wary of single-center trials"},{"title3":"Clinical biomarkers in drug discovery and development"},{"title3":"Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: live free markets and human health"},{"title3":"Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human"},{"title3":"Haunted with and hunting for viruses"},{"title3":"CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin"},{"title3":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza"},{"title3":"Preliminary report: epidemiology of the avian influenza A (H7N9) outbreak in China"},{"title3":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance"},{"title3":"Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"APACHE II:a severity of disease classification system"},{"title3":"Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia"},{"title3":"The real-time polymerase chain reaction"},{"title3":"A prediction rule to identify low-risk patients with community-acquired pneumonia"},{"title3":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia"},{"title3":"Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor"},{"title3":"Circulating angiotensin II and adrenal receptors after nephrectomy"},{"title3":"The space structure of a conformationally labile oligopeptide in solution: angiotensin"},{"title3":"Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors"},{"title3":"Renin-angiotensin system: biochemistry and mechanisms of action"},{"title3":"Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"The renin-angiotensin system in pulmonary hypertension"},{"title3":"Renin-angiotensin-aldosterone system in diabetes and hypertension"},{"title3":"The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications"},{"title3":"The role of the brain renin-angiotensin system in neurodegenerative disorders"},{"title3":"Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases"},{"title3":"Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease"},{"title3":"Activation of the renin-angiotensin system in hyperoxia-induced lung fibrosis in neonatal rats"},{"title3":"Apelin is a positive regulator of ACE2 in failing hearts"},{"title3":"Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension"},{"title3":"Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease"},{"title3":"IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus"},{"title3":"Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Clinical risks for development of the acute respiratory distress syndrome"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Epidemiology and outcome of acute respiratory failure in intensive care unit patients"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2:a new cardiac regulator"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2"},{"title3":"Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome"},{"title3":"Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis"},{"title3":"Male-female differences in fertility and blood pressure in ACE-deficient mice"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study"},{"title3":"Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia"},{"title3":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice"},{"title3":"Consequences of alteration in capillary permeability"},{"title3":"Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure"},{"title3":"PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide"},{"title3":"Hypoxia and angiotensin II infusion redistribute lung blood flow in lambs"},{"title3":"Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome"}]},{"title2":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome","References":[]},{"title2":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients","References":[{"title3":"Middle East respiratory syndrome"},{"title3":"An unexpected outbreak of Middle East respiratory syndrome coronavirus infection in the Republic of Korea, 2015"},{"title3":"The characteristics of middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea"},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia"},{"title3":"Case definition and management of patients with MERS coronavirus in Saudi Arabia"},{"title3":"2014 MERS-CoV outbreak in Jeddah - a link to health care facilities"},{"title3":"On estimating the relation between blood group and disease"},{"title3":"Treatment outcomes for patients with Middle Eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia"},{"title3":"Treatment strategies for Middle East respiratory syndrome coronavirus"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"White cell differential count and influenza A"},{"title3":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)"},{"title3":"Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis"},{"title3":"Discovery of T cell infection and apoptosis by MERS Coronavirus"},{"title3":"Middle East Respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates both the extrinsic and intrinsic apoptosis pathways"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"}]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Severe Acute Respiratory Syndrome (SARS) Epidemiology Working Group. WHO consensus document on the epidemiology of severe acute respiratory syndrome (SARS). (http://www.who.int/csr/sars/en/WHOconsensus.pdf, 2003)."},{"title3":"Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology"},{"title3":"Updating the accounts: global mortality of the 1918-1920 &quot;Spanish&quot; influenza pandemic"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"World Health Organization. Confirmed human cases of avian influenza A (H5N1), 7 September 2004. (http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2004_09_07/en/print.html, 2004)."},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Imai, Y. et al. The SARS-coronavirus receptor angiotensin coverting enzyme 2 protects from severe acute lung failure. Nature (in the press)."},{"title3":"Chemokine receptor trafficking and viral replication"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Human coronaviruses-a brief review"},{"title3":"ACE1 polymorphism and progression of SARS"},{"title3":"Analysis on the SARS-CoV genome of PUMC01 isolate"},{"title3":"Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation"}]},{"title2":"Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort","References":[{"title3":"Economic burden of COPD in the presence of comorbidities"},{"title3":"Global burden of COPD: risk factors, prevalence, and future trends"},{"title3":"Global burden of COPD: systematic review and meta-analysis"},{"title3":"Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort"},{"title3":"Seven-year cumulative incidence of COPD in an age-stratified general population sample"},{"title3":"Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study"},{"title3":"COPD in the general population: prevalence, incidence and survival"},{"title3":"Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults"},{"title3":"Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population"},{"title3":"Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles"},{"title3":"Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey"},{"title3":"An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease"},{"title3":"COPD in never smokers: results from the population-based burden of obstructive lung disease study"},{"title3":"Genome-wide association studies identify genetic loci related to alcohol consumption in Korean men"},{"title3":"Estimating the relative risk in cohort studies and clinical trials of common outcomes"},{"title3":"Estimating the population attributable risk for multiple risk factors using case-control data"},{"title3":"Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey"},{"title3":"Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm"},{"title3":"Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population"},{"title3":"Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease"},{"title3":"Prevalence and incidence of COPD in smokers and nonsmokers: the Rotterdam Study"},{"title3":"Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?"},{"title3":"Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors"},{"title3":"Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study"},{"title3":"Awareness of COPD in a high risk Korean population"},{"title3":"The diagnostic accuracies of chronic obstructive pulmonary disease (COPD) in general practice: the results of the MAGIC (Manchester Airways Group Identifying COPD) study"},{"title3":"Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Effects of calcium channel blockers comparing to angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis","References":[{"title3":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)"},{"title3":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control"},{"title3":"Renin-Angiotensin-Aldosterone System Blockade in Critically Ill Patients Is Associated with Increased Risk for Acute Kidney Injury"},{"title3":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. American journal of kidney diseases: the official journal of the"},{"title3":"Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Estimating the mean and variance from the median, range, and the size of a sample"},{"title3":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes"},{"title3":"Odds Ratio, Hazard Ratio and Relative Risk"},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial"},{"title3":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy"},{"title3":"Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy"},{"title3":"The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to moderate renal failure"},{"title3":"Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril"},{"title3":"ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial"},{"title3":"The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: A 3-year, randomized, multicenter, double-blind, placebo-controlled study"},{"title3":"Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function"},{"title3":"A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period"},{"title3":"Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency"},{"title3":"Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study"},{"title3":"Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension:a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study"},{"title3":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes"},{"title3":"A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure"},{"title3":"A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease"},{"title3":"Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency"},{"title3":"A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension"},{"title3":"Proteinuria in mild to moderate hypertension: Results of the VA cooperative study of six antihypertensive agents and placebo"},{"title3":"Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR"},{"title3":"Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"},{"title3":"Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate"},{"title3":"Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis"},{"title3":"Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease"},{"title3":"Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers"},{"title3":"Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy"},{"title3":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial"},{"title3":"Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients"},{"title3":"Long-term comparison between captopril and nifedipine in the progression of renal insufficiency"},{"title3":"Laragh's lessons in pathophysiology and clinical pearls for treating hypertension"},{"title3":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology"},{"title3":"Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans"},{"title3":"&quot;Escape&quot; of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy"},{"title3":"Vasopeptidase inhibition and angio-oedema"},{"title3":"Calcium-antagonist drugs"},{"title3":"Calcium channel blockers. Is it time to split the lump?"},{"title3":"Calcium channel blockers"},{"title3":"Role of actions of calcium antagonists on efferent arterioles:with special references to glomerular hypertension"},{"title3":"Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis"},{"title3":"When to use the odds ratio or the relative risk?"},{"title3":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients"},{"title3":"Have we attained the right control of hypertension? Consequences of the 2013 European Society of Hypertension/European Society of Cardiology and Eighth Joint National Committee recommendations"},{"title3":"Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement"}]},{"title2":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"SARS coronavirus sequencing"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS): revised 1 May 2003"},{"title3":"Pneumonia due to viral and atypical organisms and their sequelae"},{"title3":"Pneumonia: high-resolution CT findings in 114 patients"},{"title3":"Imaging of pneumonia: trends and algorithms"},{"title3":"Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital"},{"title3":"Differentiation of bacterial and viral pneumonia in children"},{"title3":"Hospital infection control guidance for severe acute respiratory syndrome (SARS): revised 24 April 2003"},{"title3":"Personal view of SARS: confusing definition, confusing diagnoses"},{"title3":"The immediate psychological and occupational impact of the 2003 SARS outbreak in teaching hospital"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Cluster of severe acute respiratory syndrome cases among protected health-care workers: Toronto, Canada, April 2003"},{"title3":"Interim domestic guidance for management of exposures to severe acute respiratory syndrome (SARS) for health-care settings"},{"title3":"Clinical course and management of SARS in health care workers in Toronto: a case series"},{"title3":"Identification and containment of an outbreak of SARS in a community hospital"},{"title3":"Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"An outbreak of coronavirus OC43 respiratory infection in Normandy, France"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"}]},{"title2":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumoniarelated outcomes","References":[]},{"title2":"An expanded definition of the adult respiratory distress syndrome","References":[]},{"title2":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice","References":[{"title3":"Passive transfer of A germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal middle east respiratory syndrome coronavirus infection"},{"title3":"Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection"},{"title3":"Pathogen genomic surveillance elucidates the origins, transmission and evolution of emerging viral agents in China"},{"title3":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV"}]},{"title2":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure","References":[]},{"title2":"Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","References":[{"title3":"Autosomal dominant polycystic kidney disease"},{"title3":"Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease"},{"title3":"The anatomy of the renin-secreting cell in adult polycystic kidney disease"},{"title3":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease"},{"title3":"Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease"},{"title3":"Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease"},{"title3":"The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease"},{"title3":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)"},{"title3":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease"},{"title3":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency"},{"title3":"Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease"},{"title3":"No effect of enalapril on progression in autosomal dominant polycystic kidney disease"},{"title3":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis"},{"title3":"Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease"},{"title3":"Blood pressure in early autosomal dominant polycystic kidney disease"},{"title3":"The HALT polycystic kidney disease trials: design and implementation"},{"title3":"Analysis of baseline parameters in the HALT polycystic kidney disease trials"},{"title3":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1"},{"title3":"Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate"},{"title3":"Shared parameter models for the joint analysis of longitudinal data and event times"},{"title3":"On the regression analysis of multivariate failure time data"},{"title3":"Group sequential procedures: calendar versus information time"},{"title3":"Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease"},{"title3":"Everolimus in patients with autosomal dominant polycystic kidney disease"},{"title3":"Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis"},{"title3":"Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease"},{"title3":"Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis"},{"title3":"Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data"},{"title3":"Dual renin-angiotensin system blockade at optimal doses for proteinuria"},{"title3":"Telmisartan, ramipril, or both in patients at high risk for vascular events"},{"title3":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multi-centre, randomised, double-blind, controlled trial"},{"title3":"Combined angiotensin inhibition for the treatment of diabetic nephropathy"},{"title3":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes"},{"title3":"Tolvaptan in patients with autosomal dominant polycystic kidney disease"}]},{"title2":"Hypoalbuminemia in acute illness: is there a rationale for intervention?","References":[]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse","References":[{"title3":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets"},{"title3":"Airborne transmission of influenza A/H5N1 virus between ferrets"},{"title3":"Innate immune responses to influenza A H 5N1: friend or foe?"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in sars coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases"},{"title3":"Renin-angiotensin system blocking drugs"},{"title3":"Cardiac Drug Therapy"},{"title3":"Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome"},{"title3":"Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]-1h-benzimidazole-7-carbo-xylate (TCV-116), in various hypertensive rats"},{"title3":"The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice"},{"title3":"How will physicians respond to the next influenza pandemic?"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes"}]},{"title2":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings","References":[]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","References":[{"title3":"Wild bird migration across the Qinghai-Tibetan plateau: a transmission route for highly pathogenic H5N1"},{"title3":"Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review"},{"title3":"Qualitative and quantitative analyses of influenza virus receptors in trachea and lung tissues of humans, mice, chickens and ducks"},{"title3":"H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes"},{"title3":"Avian influenza: public health and food safety concerns"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2--a new cardiac regulator"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Apelin is a positive regulator of ACE2 in failing hearts"},{"title3":"Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis"},{"title3":"ACE2: more of Ang-(1-7) or less Ang II?"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Human infection with highly pathogenic H5N1 influenza virus"},{"title3":"Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data"},{"title3":"Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China"},{"title3":"Avian influenza H5N1: an update on molecular pathogenesis"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection"},{"title3":"Haunted with and hunting for viruses"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome"},{"title3":"Physiology of local renin-angiotensin systems"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Bench-to-bedside review: chest wall elastance in acute lung injury/acute respiratory distress syndrome patients"},{"title3":"Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence"},{"title3":"A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity"},{"title3":"Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control"},{"title3":"Heterologous interactions between NS1 proteins from different influenza A virus subtypes/strains"},{"title3":"Methionine-101 from one strain of H5N1 NS1 protein determines its IFN-antagonizing ability and subcellular distribution pattern"},{"title3":"Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: live free markets and human health"},{"title3":"The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis"},{"title3":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals"},{"title3":"Evidence for an intrinsic angiotensin system in the canine pancreas"}]}]},{"title1":"Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases - Wuhan, China 2019-2020","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"A familiar cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China","References":[{"title3":"Wuhan Municipal Health Commission's briefing on the pneumonia epidemic situation"},{"title3":"New-type coronavirus causes pneumonia in Wuhan: expert"},{"title3":"Coronavirus"},{"title3":"Global health concern stirred by emerging viral infections"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation. Released on 26 January 2020 (in Chinese)"},{"title3":"Stop the Wuhan virus"},{"title3":"Coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Wuhan Municipal Health Commission's briefing on the pneumonia epidemic situation"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation"},{"title3":"CCTV News' briefing on the pneumonia epidemic situation"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation"},{"title3":"CCTV News' briefing on the pneumonia epidemic situation"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation"},{"title3":"China Youth Daily's briefing on the pneumonia epidemic situation"},{"title3":"China Youth Daily's briefing on the pneumonia epidemic situation"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"Acute respiratory syndrome in China-Update 3"},{"title3":"Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"Duration of symptom onset to hospital admission and admission to discharge or death in SARS in mainland China: a descriptive study"},{"title3":"Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"Interim 2019 novel coronavirus (2019-nCoV) patient under investigation (PUI) form"},{"title3":"Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected"},{"title3":"Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts"},{"title3":"Prevention and control of pneumonia from novel coronavirus infection (2nd ed.)"}]},{"title2":"A novel coronavirus outbreak of global health concern","References":[{"title3":"Novel coronavirus - Thailand (ex-China). Geneva: World Health Organization"},{"title3":"Novel Coronavirus - Japan (ex-China). Geneva: World Health Organization"},{"title3":"Update on the novel coronavirus pneumonia outbreak (Jan 24, 2020). Beijing: China National Health Commission"},{"title3":"Novel coronavirus - Republic of Korea (ex-China). Geneva: World Health Organization"},{"title3":"First travel-related case of 2019 novel coronavirus detected in United States. Atlanta, GA: US Centers for Disease Control and Prevention"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Novel coronavirus (2019-nCoV) situation report - 2 (22 January 2020). Geneva: World Health Organization"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV). Geneva: World Health Organization"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization"},{"title3":"Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, World Health Organization"},{"title3":"Announcement from the Headquarter for novel coronavirus pneumonia prevention and control (No 1). Beijing: China National Health Commission"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Geneva, World Health Organization"}]},{"title2":"China coronavirus: WHO declares international emergency as death toll exceeds 200","References":[]},{"title2":"Severe acute respiratory syndrome: clinical and laboratory manifestations","References":[]},{"title2":"The Middle East Respiratory Syndrome (MERS)","References":[]},{"title2":"The novel coronavirus in Wuhan, China: challenges for global health governance","References":[]},{"title2":"The extent of transmission of novel coronavirus in Wuhan, China, 2020","References":[{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:The latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Wuhan Municipal Health Commission's Briefing on the Current Pneumonia Epidemic in the City"},{"title3":"Novel Coronavirus:Japan (ex-China)"},{"title3":"Novel Coronavirus:Republic of Korea (ex-China)"},{"title3":"Novel Coronavirus (2019-nCoV) Situation Report:1"},{"title3":"2019 Novel Coronavirus, Wuhan, China"},{"title3":"Wuhan Coronavirus Death Toll Rises to Nine with 453 Infected Says China, Sparking Fears of Wider Spread"},{"title3":"World Tourism Organization"},{"title3":"CEIC, Global Economic Data"},{"title3":"International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017"},{"title3":"Dynamics of the pneumonic plague epidemic in Madagascar, August to October 2017"},{"title3":"Investigation of the proportion of diagnosed people living with HIV/AIDS among foreign residents in Japan"},{"title3":"Incubation periods of acute respiratory viral infections: A systematic review"},{"title3":"Outbreak of Patients with Pneumonia Associated with Novel Coronavirus"},{"title3":"Novel Coronavirus:Thailand (ex-China)"},{"title3":"Ministry of Public Health Receives 2 Tourists from Wuhan for Pneumonia at Bamrasnaradura Institute"},{"title3":"First Confirmed Case of New Coronavirus Pneumonia in Taiwan"},{"title3":"Case of 2019 Novel Coronavirus Confirmed in Washington State Resident"},{"title3":"Macau Confirms First Wuhan Virus Case, Tightens Screening in Casinos"},{"title3":"Wuhan Virus: 2 More Cases Confirmed in Thailand"},{"title3":"Confirmed imported case of novel coronavirus infection in Singapore; Multi-ministry taskforce ramps up precautionary measures"},{"title3":"Vietnam confirms first 2 novel coronavirus cases"},{"title3":"Novel pneumonia, 2nd case confirmed. Tourist from Wuhan"},{"title3":"South Korea reports 2nd confirmed case of Wuhan coronavirus"},{"title3":"Imperial College London-MRC Centre for Global Infectious Disease Analysis. News/Wuhan Coronavirus"},{"title3":"Pneumonia of unknown etiology in Wuhan, China: Potential for international spread via commercial air travel"},{"title3":"Laboratory for the Modeling of Biological and Socio-Technical Systems"},{"title3":"The University of Hong Kong-HKUMed WHO Collaborating Centre for Infectious Disease Epidemiology and Control"}]},{"title2":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia","References":[]},{"title2":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing","References":[]},{"title2":"CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia","References":[{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Emerging 2019 novel coronavirus (2019-nCoV) pneumonia"}]},{"title2":"Emerging coronavirus 2019-nCoV pneumonia","References":[]},{"title2":"Imaging profile of the COVID-19 infection: radiologic findings and literature review","References":[{"title3":"Novel Coronavirus(2019-nCoV) Situation Report - 11"},{"title3":"Novel Coronavirus(2019-nCoV) Situation Report - 17"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Emerging Coronavirus 2019-nCoV Pneumonia"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"Severe acute respiratory syndrome: radiographic and CT findings"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Severe acute respiratory syndrome: radiographic evaluation and clinical outcome measures"},{"title3":"A Novel Coronavirus emerging in China - key questions for impact assessment"}]},{"title2":"Chest imaging appearance of COVID-19 infection","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist"},{"title3":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission"}]},{"title2":"The many faces of COVID-19: spectrum of imaging manifestations","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Imaging Profile of the COVID-2019 Infection: Radiologic Findings and Literature Review"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Emerging Coronavirus 2019-nCoV Pneumonia"},{"title3":"Chest imaging appearance of COVID-19 infection"},{"title3":"&quot;Crazy-paving&quot; pattern at thin-section CT of the lungs: radiologic-pathologic overview"},{"title3":"From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia"},{"title3":"Longitudinal CT findings in COVID-19 pneumonia: case presenting organizing pneumonia pattern"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Imaging of pulmonary viral pneumonia"},{"title3":"COVID-19 Infection Presenting with CT Halo Sign"},{"title3":"The CT Halo Sign"},{"title3":"Spectrum of Chest CT Findings in a Familial Cluster of COVID-19 Infection"},{"title3":"Severe Acute Respiratory Disease in a Huanan Seafood Market Worker: Images of an Early Casualty"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"}]},{"title2":"Longitudinal CT findings in COVID-19 pneumonia: case presenting organizing pneumonia pattern","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"}]},{"title2":"Spectrum of chest CT findings in a familial cluster of COVID-19 infection","References":[]},{"title2":"COVID-19 infection presenting with CT halo sign","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"The CT halo sign"}]},{"title2":"CT imaging features of 2019 novel coronavirus (2019-nCoV)","References":[{"title3":"Novel Coronavirus - China. World Health Organization"},{"title3":"Novel Coronavirus (2019-nCoV). World Health Organization"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV). World Health Organization"},{"title3":"Situation report - 8. World Health Organization"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"About 2019 Novel Coronavirus (2019-nCoV). Centers for Disease Control and Prevention"},{"title3":"Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience"}]},{"title2":"Fleischner Society: glossary of terms for thoracic imaging","References":[]},{"title2":"China's Hubei reports jump in new cases of COVID-19 after diagnosis criteria revision","References":[]}]}]}